As Wealthy Get Dengue Fever, Drug Companies More Likely to Act (Asia)
This article was originally published in PharmAsia News
Executive Summary
A recent report has found that rates of dengue infection are on the rise. Singapore has reported over 5,000 infections while India has over 100,000 recorded, including over 1,000 deaths. Recorded in the journal Nature, the report notes that infection rates are becoming particularly prevalent in wealthy and middle class Asian communities. Advocates for a dengue vaccine hope this trend will encourage major pharmaceutical companies to consider developing better preventative treatments. Their involvement would be essential since developing the vaccine is likely to be a costly proposition. Experts note any vaccine would have to be capable of addressing at least four strains of the virus to prove effective. (Click here for more